-transparent.png){kind=logo}
The levels of adenosine diphosphate ribosyl transferase (ADPRT) have been quantified in Ficoll-Isopaque isolated marrow cells from 36 patients with acute myeloid leukemia (AML). The in vitro growth pattern in agar at diagnosis was also determined, and in 16 patients the in vitro drug sensitivity of the clonogenic cells (CFU-GM) to cytosine arabinoside and daunorubicin was measured. The ADPRT activities of the various marrow cell preparations correlated to the morphological diagnoses, in vitro growth patterns, in vitro drug sensitivities to cytosine arabinoside, and to the prognoses of the AML patients. Hence, ADPRT may be a useful marker for the pathophysiology associated to AML.
R W Pero, and
T Olofsson, and
A Gustavsson, and
E Kjellén
January 1983,
Princess Takamatsu symposia,
R W Pero, and
T Olofsson, and
A Gustavsson, and
E Kjellén
December 1988,
Gut,
R W Pero, and
T Olofsson, and
A Gustavsson, and
E Kjellén
January 1985,
Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie,
R W Pero, and
T Olofsson, and
A Gustavsson, and
E Kjellén
May 1987,
Molecular and biochemical parasitology,
R W Pero, and
T Olofsson, and
A Gustavsson, and
E Kjellén
May 2022,
Blood advances,
R W Pero, and
T Olofsson, and
A Gustavsson, and
E Kjellén
January 1985,
Acta radiologica. Oncology,
R W Pero, and
T Olofsson, and
A Gustavsson, and
E Kjellén
March 1988,
Carcinogenesis,
R W Pero, and
T Olofsson, and
A Gustavsson, and
E Kjellén
January 1985,
International archives of allergy and applied immunology,
R W Pero, and
T Olofsson, and
A Gustavsson, and
E Kjellén
December 2003,
Journal of vascular surgery,
R W Pero, and
T Olofsson, and
A Gustavsson, and
E Kjellén
January 1992,
Leukemia,
